Cargando…

Correction: Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595186/ https://www.ncbi.nlm.nih.gov/pubmed/28948029 http://dx.doi.org/10.1136/bmjdrc-2017-000391corr1

Ejemplares similares

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
por: Kitada, Munehiro, et al.
Publicado: (2017)

Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction
por: Okazaki, Yusuke, et al.
Publicado: (2014)

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
por: Iijima, Takahiro, et al.
Publicado: (2020)

Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage
por: Zhao, Yue, et al.
Publicado: (2017)

Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy
por: Huang, Yan, et al.
Publicado: (2012)

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
por: Nishio, Shinya, et al.
Publicado: (2015)

Being overweight worsens the relationship between urinary sodium excretion and albuminuria: the Wakuya study
por: Tagawa, Kaname, et al.
Publicado: (2023)

Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus
por: Chiba, Yukari, et al.
Publicado: (2018)

Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus
por: Nomura, Shosaku, et al.
Publicado: (2023)

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2010)

Significance of urinary albumin excretion in patients with cast nephropathy
por: Nakagawa, Ryo, et al.
Publicado: (2019)

Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
por: Katayama, Masaaki, et al.
Publicado: (2020)

A Study of Association of Urinary Nephrin with Albuminuria in Patients with Diabetic Nephropathy
por: Kondapi, Kishore, et al.
Publicado: (2021)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
por: Stangenberg, Stefanie, et al.
Publicado: (2018)

Mangiferin Ameliorates Hyperuricemic Nephropathy Which Is Associated With Downregulation of AQP2 and Increased Urinary Uric Acid Excretion
por: Li, Xuechen, et al.
Publicado: (2020)

Utility of Urinary Nephrin in Patients With and Without Diabetic Nephropathy and Its Correlation With Albuminuria
por: Surya, Manupati, et al.
Publicado: (2021)

Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
por: Sinkeler, Steef J., et al.
Publicado: (2013)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
por: Kurozumi, Akira, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose
por: Katoh, Shuichi, et al.
Publicado: (2020)

Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy
por: Viswanathan, V., et al.
Publicado: (2015)

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy
por: Ogawa, Susumu, et al.
Publicado: (2009)

Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials
por: van der Aart ‐ van der Beek, Annemarie B., et al.
Publicado: (2020)

Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2011)

Albuminuria Intensifies the Link Between Urinary Sodium Excretion and Central Pulse Pressure in the General Population: The Wakuya Study
por: Tagawa, Kaname, et al.
Publicado: (2021)

Addition of nonalbumin proteinuria to albuminuria improves prediction of type 2 diabetic nephropathy progression
por: Kim, Jong Ho, et al.
Publicado: (2017)

Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy
por: Chen, Yung‐Nien, et al.
Publicado: (2020)

Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
por: Kim, So Ra, et al.
Publicado: (2017)

Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy
por: Rossi, Luigi, et al.
Publicado: (2017)

Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study
por: Kishimoto, Miyako, et al.
Publicado: (2014)

YKL-40 levels are independently associated with albuminuria in type 2 diabetes
por: Røndbjerg, Anne K, et al.
Publicado: (2011)

Relationship between Urinary Calcium Excretion and Lower Urinary Tract Symptoms
por: Matsuo, Tomohiro, et al.
Publicado: (2022)

A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis
por: Zhang, Li, et al.
Publicado: (2022)

Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport
por: Goto, Moritaka, et al.
Publicado: (2018)

Urinary Angiopoietin-2 Is Associated with Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Chen, Shan, et al.
Publicado: (2015)

Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study
por: Li, Fengqin, et al.
Publicado: (2018)

Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
por: Leong, Amanda, et al.
Publicado: (2017)

Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy
por: Kaleta, Beata, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ch2ti05fsb4gfsp445fp5p9e8e